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Participation of patients in decisions about
treatment for cancer
Desire for information is not the same as a desire to participate in decision making
The primary aim of treatment for cancer is toimprove the quality of life of patients by curingthem or producing a long and worthwhile
remission and ameliorating their worst symptoms. For
many types of cancers, however, the most appropriate
management is not always clear or based on the best
evidence from well conducted randomised controlled
trials.
Clinicians may have more than one therapeutic
option to offer patients and there are many calls for
more involvement of patients in decision making about
their treatment. Two fundamental issues should be
determined when discussing treatment choices with
patients—their own preferences about the amount and
type of information that is needed and their actual
rather than perceived desire for participation in
decision making. A clear distinction needs to be made
between a desire for information and a wish to assume
responsibility for decision making. They are not one
and the same thing. In one study of women with breast
cancer, improvements in quality of life brought about
by reduced anxiety and depression and better
adjustment were primarily related to satisfaction with
information they got, not merely involvement with
decision making about the type of surgery.1
Many studies have shown that patients want much
more information than their doctors believe they do.2
We also know that the ability of doctors to predict
which patients want an active, shared, or passive role in
decision making is very poor in palliative care and
when active, potentially curative treatment is dis›
cussed.3 4 Patients’ preferences about choice of
treatment are poorly understood and usually based on
intuitive assumptions about their perceived intelli›
gence, age, or quality of life. This problem is not
confined to the United Kingdom, although the poor
ratio of oncologists to patients does mean that good
patient centred communication about choices avail›
able and their consequences is easily omitted in busy
clinics. We await with interest more results from the
study to understand prognoses and preferences for
outcomes and risks of treatments from the United
States.5
The choices of treatment put before patients
should involve an adequate and objective appraisal of
information, delivered in a patient centred manner
backed by information booklets, audio and video tapes,
and references to good websites such as those provided
by CancerBACUP, the new National electronic Library
for Health (NeLH), and the DIPEx database.6–8
Unfortunately even when evidence concerning
improved survival or disease free intervals exists, data
on quality of life are either missing, sketchy, or not well
integrated into the analysis of overall benefit. There is
some evidence that doctors do not collect accurate
information about symptoms that affect quality of life;
consequently patients may be agreeing to different
treatments without being aware of their side effects.9
Further, doctors admit to having difficulty integrating
the results from formal assessment of quality of life by
questionnaires into clinical management, preferring to
rely on their own clinical impressions about tolerability
or impact of side effects.10 Arguably in some situations,
including adjuvant therapy and palliation, these quality
of life parameters might be the most important areas
of information that a patient requires about likely
benefit before consenting to treatment.
Patients cannot participate in decision making to
their desired extent unless they have the right types of
information, given in ways optimal for their own level
of understanding. There is a compelling need for
training and other interventions to help communica›
tion between doctors and patients about the likely and
preferred therapeutic goals and priorities of treatment.
True patient participation, which may include an
expressed preference by the patient to assume a more
passive role about the type of information they require,
and involvement in decision making is, for most, an
unachievable goal unless we see some real improve›
ments in the current system of healthcare delivery. Too
many patients are being seen by too few doctors in
over burdened clinics with inadequate support staff for
meeting adequately the individual information needs
of patients with cancer.
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